Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    32941 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Stem Cell Factor Medication for Aplastic Anemia
Conditions: Aplastic Anemia;   Pancytopenia
Intervention: Drug: Recombinant Methionyl Human Stem Cell Factor (r-metHuSCF)

Study has passed its completion date and status has not been verified in more than two years.